TY - JOUR
T1 - Transcriptional dynamics during human adipogenesis and its link to adipose morphology and distribution
AU - Ehrlund, Anna
AU - Mejhert, Niklas
AU - Björk, Christel
AU - Andersson, Robin
AU - Kulyté, Agné
AU - Åström, Gaby
AU - Itoh, Masayoshi
AU - Kawaji, Hideya
AU - Lassmann, Timo
AU - Daub, Carsten O.
AU - Carninci, Piero
AU - Forrest, Alistair R. R.
AU - Hayashizaki, Yoshihide
AU - Sandelin, Albin Gustav
AU - Ingelsson, Erik
AU - FANTOM Consortium, null
AU - Rydén, Mikael
AU - Laurencikiene, Jurga
AU - Arner, Peter
AU - Arner, Erik
N1 - © 2016 by the American Diabetes Association.
PY - 2017/1/1
Y1 - 2017/1/1
N2 - White adipose tissue (WAT) can develop into several phenotypes with different pathophysiological impact on type 2 diabetes. To better understand the adipogenic process, the transcriptional events that occur during in vitro differentiation of human adipocytes were investigated and the findings linked to WAT phenotypes. Singlemolecule transcriptional profiling provided a detailed map of the expressional changes of genes, enhancers, and long noncoding RNAs, where different types of transcripts share common dynamics during differentiation. Common signatures include early downregulated, transient, and late induced transcripts, all of which are linked to distinct developmental processes during adipogenesis. Enhancers expressed during adipogenesis overlap significantly with genetic variants associated with WAT distribution. Transiently expressed and late induced genes are associated with hypertrophic WAT (few but large fat cells), a phenotype closely linked to insulin resistance and type 2 diabetes. Transcription factors that are expressed early or transiently affect differentiation and adipocyte function and are controlled by several well-known upstream regulators such as glucocorticosteroids, insulin, cAMP, and thyroid hormones. Taken together, our results suggest a complex but highly coordinated regulation of adipogenesis.
AB - White adipose tissue (WAT) can develop into several phenotypes with different pathophysiological impact on type 2 diabetes. To better understand the adipogenic process, the transcriptional events that occur during in vitro differentiation of human adipocytes were investigated and the findings linked to WAT phenotypes. Singlemolecule transcriptional profiling provided a detailed map of the expressional changes of genes, enhancers, and long noncoding RNAs, where different types of transcripts share common dynamics during differentiation. Common signatures include early downregulated, transient, and late induced transcripts, all of which are linked to distinct developmental processes during adipogenesis. Enhancers expressed during adipogenesis overlap significantly with genetic variants associated with WAT distribution. Transiently expressed and late induced genes are associated with hypertrophic WAT (few but large fat cells), a phenotype closely linked to insulin resistance and type 2 diabetes. Transcription factors that are expressed early or transiently affect differentiation and adipocyte function and are controlled by several well-known upstream regulators such as glucocorticosteroids, insulin, cAMP, and thyroid hormones. Taken together, our results suggest a complex but highly coordinated regulation of adipogenesis.
U2 - 10.2337/db16-0631
DO - 10.2337/db16-0631
M3 - Journal article
C2 - 27803022
SN - 0012-1797
VL - 66
SP - 218
EP - 230
JO - Diabetes
JF - Diabetes
IS - 1
ER -